SCHEMBL25243441

SCHEMBL25243441

CCCN(C)CCc1c[nH]c2ccc(C)c(O)c12

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HTR2A P28223 10/20 0.47
▸ HTR1A P08908 9/20 0.47
▸ HTR2C P28335 7/20 0.47
▸ HTR2B P41595 6/20 0.47
▸ HTR1D P28221 6/20 0.47
▸ HTR6 P50406 2/20 0.47
▸ HTR1B P28222 2/20 0.47
▸ DRD1 P21728 1/20 0.47
▸ HTR1E P28566 1/20 0.47
▸ ADORA2A P29274 1/20 0.47
▸ ADORA2B P29275 1/20 0.47
▸ HTR7 P34969 1/20 0.47
▸ DRD3 P35462 1/20 0.47
▸ HTR5A P47898 1/20 0.47
▸ SLC6A4 P31645 1/20 0.41
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30483761 1.00 HTR2A (0.47) HTR2AHTR1AHTR2CHTR2BHTR1D
SCHEMBL25282962 0.90 HTR2A (0.51) HTR2AHTR1AHTR2CHTR2BHTR1D
SCHEMBL25288837 0.88 HTR1D (0.58) HTR2AHTR1AHTR2CHTR2BHTR1D
SCHEMBL30630302 0.86 HTR2A (0.62) HTR2AHTR1AHTR2CHTR2BHTR1D
SCHEMBL25747584 0.86 HTR2A (0.62) HTR2AHTR1AHTR2CHTR2BHTR1D
SCHEMBL25241520 0.83 HTR1A (0.64) HTR2AHTR1AHTR2CHTR2BHTR1D
SCHEMBL25241983 0.81 HTR2A (0.47) HTR2AHTR1AHTR2CHTR2BHTR1D
SCHEMBL25288798 0.80 HTR1A (0.56) HTR2AHTR1AHTR2CHTR2BHTR1D
SCHEMBL31077923 0.80 HTR1A (0.56) HTR2AHTR1AHTR2CHTR2BHTR1D
SCHEMBL25287186 0.80 HTR2A (0.56) HTR2AHTR1AHTR2CHTR2BHTR1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250101038-A1 COMPOUNDS Psylo Pty Ltd (AU) 2025-03-27 — — US disclosed
EP-4452937-A1 COMPOUNDS Psylo Pty Ltd (AU) 2024-10-30 — — EP disclosed
WO-2023115166-A1 COMPOUNDS Psylo Pty Ltd (AU) 2023-06-29 — — WO disclosed
WO-2023115166-A1 COMPOUNDS Psylo Pty Ltd (AU) 2023-06-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250101038-A1 COMPOUNDS NLN, SLC18A2, PYGB HTR2A 94/4885HTR1A 185/4885HTR2C 23/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback